Purpose: The treatment options for viral myocarditis caused by coxsackievirus B are summarized. Summary: Myocarditis is a common cause of dilated cardiomyopathy. The most common causes of infectious ...

Despite being younger and having fewer comorbidities, patients with acute myocarditis (AM) had a significantly higher risk for 30-day and long-term mortality than those with unexplained chest pain.

Change in the primary endpoint of left ventricular (LV) extracellular volume (ECV) showed a notable improvement (p = 0.0538) favouring CardiolRx™ over placebo. Reduction in ECV was associated with ...

Madrid, Spain – 29 August: New ESC Guidelines to improve the diagnosis and care of patients with myocarditis and pericarditis, have been published today at ESC Congress 2025. This is the first time ...

Stanford researchers identify a two-step immune reaction underlying rare myocarditis cases after mRNA COVID vaccination, primarily in adolescent males and young men. Cases typically resolve quickly ...

Myocarditis describes the inflammation of the heart muscle, which can be caused by enterovirus infections. Understanding how viruses infect cardiac cells and trigger an immune response is crucial for ...

The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

Premenopausal women presenting with acute coronary syndrome (ACS) are a unique and often underrecognized patient population. Although they are traditionally considered at lower cardiovascular risk ...

ARCHER is designed to assess the impact of CardiolRx™ on cardiac magnetic resonance imaging parameters that measure heart dysfunction and edema/fibrosis-key measurements used to predict prognosis in ...